Erlotinib Completed Phase 1 Trials for Advanced Cancers / Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01532011Erlotinib in Combination With Pralatrexate in Advanced Malignancies